Nuestro grupo organiza más de 3000 Series de conferencias Eventos cada año en EE. UU., Europa y América. Asia con el apoyo de 1.000 sociedades científicas más y publica más de 700 Acceso abierto Revistas que contienen más de 50.000 personalidades eminentes, científicos de renombre como miembros del consejo editorial.
Revistas de acceso abierto que ganan más lectores y citas
700 revistas y 15 000 000 de lectores Cada revista obtiene más de 25 000 lectores
Mei Zhang, Grant A Moore, Richard Everts and Evan J Begg
A rapid, simple and sensitive liquid chromatography/tandem mass spectrometry (LC-MS/MS) assay was developed for the determination of total and free concentrations of flucloxacillin and cefazolin in human plasma. Free flucloxacillin and cefazolin were separated from bound drug by ultra filtration. Samples of plasma and plasma ultra filtrate were pre-treated with acetonitrile (sample: acetonitrile = 1:4). Flucloxacillin, cefazolin and butobarbitone, the internal standard, were then resolved on a C18 (2)column using gradient elution of 0.05% formic acid and methanol. The three compounds were detected using electrospray ionisation in the positive mode. Standard curves were linear over the concentration range 0.2 to 100 mg/L (r>0.99) in plasma and 0.005 to 10 mg/L (r>0.99) in plasma ultra filtrate for both flucloxacillin and cefazolin. For both total and free flucloxacillin and cefazolin, bias was <±10%, and intra- and inter-day coefficients of variation (imprecision) were <10%. The limit of quantification was 0.2 mg/L for both flucloxacillin and cefazolin in plasma. The limit of quantification was 0.005 mg/L for both flucloxacillin and cefazolin in plasma ultra filtrate. The assay has been used successfully in a clinical pharmacokinetic study of flucloxacillin, and in clinical practice to enhance the effective use of flucloxacillin and cefazolin.